DarioHealth Corp. (NASDAQ: DRIO) has launched DarioIQ™, an innovative AI layer in the Dario Health app, which marks a significant milestone in its GenAI roadmap. This first version is tailored for hypertension members, enhancing the platform with seamless, conversational AI while preserving human-centered support crucial for chronic condition management. Built on Dario’s proprietary models and 13 billion real-world data points, DarioIQ™ integrates behavioral insights and real-time biometric interpretation, ensuring user engagement through personalized guidance and timely interventions.
This direct-to-consumer approach allows Dario to refine the user experience and validate safety before expanding the AI capabilities throughout diabetes, weight management, and other chronic conditions. With a commitment to user-centric care and continuous support, Dario’s platform empowers individuals to manage their health proactively, transforming how chronic conditions are addressed and improving overall patient satisfaction. For more details on Dario’s digital health solutions, visit DarioHealth.
